Article ; Online: Management of upper gastrointestinal symptoms in patients with autoimmune gastritis.
Current opinion in gastroenterology
2022 Volume 38, Issue 6, Page(s) 600–606
Abstract: Purpose of review: Autoimmune gastritis is characterized by atrophy of acid secreting parietal cells resulting in achlorhydria. Upper gastrointestinal symptoms are common in autoimmune gastritis and frequently result in prescriptions for acid ... ...
Abstract | Purpose of review: Autoimmune gastritis is characterized by atrophy of acid secreting parietal cells resulting in achlorhydria. Upper gastrointestinal symptoms are common in autoimmune gastritis and frequently result in prescriptions for acid suppressant medications despite the inability of the stomach to secrete acid. Evidence-based recommendations for management of gastrointestinal symptoms in autoimmune gastritis are lacking. Recent findings: The most common symptoms in patients with autoimmune gastritis are dyspepsia, heartburn, and regurgitation. Gastroesophageal reflux should be confirmed by pH-impedance testing and is typically weakly acid or alkaline. Therapy for reflux focuses on mechanical prevention of reflux (i.e., elevation of the head of the bed and alginates) or when severe, antireflux surgery. The etiology of dyspepsia in autoimmune gastritis is unclear and largely unstudied. In the first half of the 20th century, oral administration of acid to "aid digestion" was widely used with reported success. However, randomized, placebo-controlled trials are lacking. Here, we provide suggestions for attempting gastric acidification therapy. Summary: Upper GI symptoms are common in autoimmune gastritis. Their pathogenesis and therapy remain incompletely understood. Acid suppressant medications are useless and should be discontinued. A trial of acid replacement therapy is recommended especially in the form of placebo-controlled trials. |
---|---|
MeSH term(s) | Alginates/therapeutic use ; Dyspepsia/drug therapy ; Gastritis/diagnosis ; Gastritis/drug therapy ; Gastroesophageal Reflux/drug therapy ; Gastroesophageal Reflux/therapy ; Heartburn/drug therapy ; Humans |
Chemical Substances | Alginates |
Language | English |
Publishing date | 2022-09-09 |
Publishing country | United States |
Document type | Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. |
ZDB-ID | 632571-3 |
ISSN | 1531-7056 ; 0267-1379 |
ISSN (online) | 1531-7056 |
ISSN | 0267-1379 |
DOI | 10.1097/MOG.0000000000000878 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2072: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.